Benchmark Electronics(BHE) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Fourth quarter revenue reached $704 million, reflecting a high single-digit growth and exceeding prior guidance [5][11] - Full year revenue for 2025 was $2.66 billion, flat compared to the previous year, but showed improving momentum throughout the year [6][12] - Fourth quarter earnings per share (EPS) was $0.71, surpassing the guidance range of $0.62-$0.68 [11] - Non-GAAP gross margin for Q4 was 10.6%, up 50 basis points sequentially and 20 basis points year-over-year [11][12] - Full year non-GAAP EPS increased by 5% to $2.40, while non-GAAP operating margin was 4.9%, down 20 basis points year-over-year [12] Business Line Data and Key Metrics Changes - Semi-Cap revenue decreased by 8% quarter-over-quarter and 14% year-over-year, but grew 2% for the full year [12][13] - Industrial revenue was flat for the full year but up 3% year-over-year [13] - Aerospace & Defense (A&D) revenue grew 17% year-over-year and 19% for the full year [13] - Medical sector revenue increased by 23% year-over-year, with a full year growth of 7% [13][14] - AC&C revenue rebounded in Q4, up 27% year-over-year, and is expected to continue this momentum into Q1 [14] Market Data and Key Metrics Changes - The semi-cap market is expected to see a demand inflection in the back half of 2026, with early signs of improvement noted [22] - Industrial sector performance is gradually improving, driven by demand in transportation, HVAC, and automation [22] - A&D revenue growth is expected to moderate in 2026 due to program timing, but bookings momentum in space applications is strong [23][24] - Medical sector is anticipated to maintain double-digit growth in 2026, supported by new program ramps [24] - AC&C is expected to leverage strong performance in computing and AI infrastructure [25] Company Strategy and Development Direction - The company targets five core high-value markets, focusing on complex, high-mix opportunities while avoiding commoditized markets [7] - Continued investment in global precision technology and production equipment aligns with new business wins [10] - The company aims to maintain a disciplined approach to operational efficiency and working capital management [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the momentum of bookings and improving end-market conditions, particularly in medical and semi-cap sectors [25] - The company remains committed to shareholder-friendly capital allocation, including dividends and share repurchases [26] - Management anticipates mid-single-digit growth guidance for 2026, with potential for further strengthening as visibility improves [26] Other Important Information - The company generated $85 million in free cash flow for the fiscal year and maintained a net cash positive position of $111 million [16] - A non-cash impairment of $11.1 million was recorded on certain assets due to program end-of-life [19] - The cash conversion cycle improved to 67 days, with significant improvements in inventory management [18] Q&A Session Summary Question: Areas of increased confidence beyond Semi-Cap - Management noted improved performance in medical and AC&C sectors, with momentum expected to continue [31] Question: Insights on gross margins and operating leverage - Management indicated that while gross margins are stable, operating margin leverage is expected to improve as revenue accelerates [32] Question: Expansion of Total Addressable Market (TAM) in industrial - Management highlighted opportunities in various subsectors such as HVAC, transportation, and agriculture [41] Question: Details on medical program wins - Management confirmed wins in medical devices and life sciences, with momentum expected to carry into 2026 [54] Question: Timeline for semi-cap recovery - Management indicated that orders could be responded to within 1-3 months, with a positive outlook for 2026 [58]